Highlights in Lung Cancer, 2013: MEK Inhibitors for KRAS Mutation-Positive NSCLC (video)

Highlights in Lung Cancer, 2013: MEK Inhibitors for KRAS Mutation-Positive NSCLC (video)

Desde: GRACEcast
0 0 hace 7 años
00:00
05:26
Medicina, #2012, #advanced, #cancer, #cancergrace, #grace, #gracecast, #highlights, #hospital, #in, #inhibitor, #kras, #lung, #margaret, #mutation, #natasha, #nsclc, #of, #princess, #toronto, #university
Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, reviews exciting new data illustrating the potential benefits of the MEK inhibitor selumetinib in treating KRAS mutation-positive advanced non-small cell lung cancer.

Autor

cancerGRACE Meetings
cancerGRACE Meetings 2 followers Follow

Síguenos en Facebook

Spreaker logo
  • Elegir idioma

Para podcasters y editores

Herramientas para podcasters

Para oyentes

Copyright 2021 - Spreaker Inc. a Voxnest Company - Crear un Podcast - New York, NY